Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

1.015
+0.0353.57%
Volume:2.82M
Turnover:3.00M
Market Cap:732.83M
PE:-3.29
High:1.145
Open:1.000
Low:1.000
Close:0.980
52wk High:2.340
52wk Low:0.900
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:7.78
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.308
ROE:-9.09%
ROA:-7.08%
PB:0.26
PE(LYR):-3.29
PS:17.67

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
BRII-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
75
Office Location:
Building 7, International Science Park,3rd Floor, Zhongguancun Dongsheng,No. 1 North Yongtaizhuang Road,Haidian District,Beijing,China
Website:
http://www.briibio.com
Zip Code:
100192
Phone:
- -
Fax:
- -
Introduction:
Brii Biosciences Ltd is a biotechnology company primarily engaged in the development of therapies for infectious diseases and central nervous system diseases. The Company's main products include BRII-179, a candidate drug for hepatitis B virus (HBV) immunotherapy, Tobevibart, an investigational neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg), as well as soralimixin (BRII-693), a synthetic lipopeptide for treating multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections. The Company primarily operates its businesses in the domestic market.

Directors

Name
Position
Zhi Hong
Chairman of the Board,Executive Director,Member of the Nomination Committee
LI An Kang
Executive Director,Chairman of the Strategic and Development Committee
Grace Hui TANG
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit and Risk Management Committee Chairman
TSUI Yiu Wa Alec
Independent Director,Member of the Remuneration and Assessment Committee,Audit and Risk Management Committee Member
Gregg H. Alton
Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee
Martin J Murphy JR
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
YANG Tai Ying
Independent Director,Member of the Strategic and Development Committee,Audit and Risk Management Committee Chairman

Shareholders

Name
Position
Zhi Hong
CEO
Eleanor (Ellee) de Groot
CTO
LI An Kang
COO,Corporate Secretary
HE Yong Zi
Corporate Secretary
Brian Alvin Johns
Chief Science Officer
David Margolis
Other Senior Executives,Other Senior Executives
Karen D. Neuendorff
Other Senior Executives
ZHU Qing
Other Senior Executives
CAO Hai Feng
Other Senior Executives